Atossa Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATOS and other ETFs, options, and stocks.About ATOS
Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C.
CEOSteven C. Quay
CEOSteven C. Quay
Employees15
Employees15
HeadquartersSeattle, Washington
HeadquartersSeattle, Washington
Founded2008
Founded2008
Employees15
Employees15
ATOS Key Statistics
Market cap95.15M
Market cap95.15M
Price-Earnings ratio-3.12
Price-Earnings ratio-3.12
Dividend yield—
Dividend yield—
Average volume1.49M
Average volume1.49M
High today$0.7401
High today$0.7401
Low today$0.7013
Low today$0.7013
Open price$0.71
Open price$0.71
Volume945.80K
Volume945.80K
52 Week high$1.29
52 Week high$1.29
52 Week low$0.5526
52 Week low$0.5526
Stock Snapshot
Atossa Therapeutics(ATOS) stock is priced at $0.72, giving the company a market capitalization of 95.15M. It carries a P/E multiple of -3.12.
As of 2025-12-20, Atossa Therapeutics(ATOS) stock has fluctuated between $0.70 and $0.74. The current price stands at $0.72, placing the stock +2.2% above today's low and -3.2% off the high.
Atossa Therapeutics(ATOS) shares are trading with a volume of 945.8K, against a daily average of 1.49M.
During the past year, Atossa Therapeutics(ATOS) stock moved between $0.55 at its lowest and $1.29 at its peak.
During the past year, Atossa Therapeutics(ATOS) stock moved between $0.55 at its lowest and $1.29 at its peak.
People also own
Based on the portfolios of people who own ATOS. This list is generated using Robinhood data, and it’s not a recommendation.